Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

<< Previous

Bullboard Posts

Next >>

Post by HighSkies2019on Jul 18, 2021 1:47pm

200 Views

Post# 33566958

Short Squeeze !!!

All this talk and rumbling about wanting to short this stk....any chance fridays total volume is an indication of a short squeeze about to happen ...67571 total which is the lowest since trading coming of the halt.. they say that when the short interest is about 5x the daily trading volume could be a sign of a short squeeze about to happen...chk out the qtys on stockwatch ....total volume dropped drastically on Friday...the next lowest day was 199k couple weeks back...256k and way higher ....maybe thats why we are hearing some noise on shorting ... and if there's no short squeeze gonna happen this week....let's get the rs done and see what direction on price ....glta

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China